MET-independent lung cancer cells evading EGFR kinase inhibitors are therapeutically susceptible to BH3 mimetic agents

Weiwen Fan, Zhe Tang, Lihong Yin, Bei Morrison, Said Hafez-Khayyata, Pingfu Fu, Honglian Huang, Rakesh Bagai, Shan Jiang, Adam Kresak, Scott Howell, Amit Vasanji, Chris A. Flask, Balazs Halmos, Henry Koon, Patrick C. Ma

Research output: Contribution to journalArticle

52 Scopus citations
Original languageEnglish (US)
Pages (from-to)4494-4505
Number of pages12
JournalCancer Research
Volume71
Issue number13
DOIs
StatePublished - Jul 1 2011

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Fan, W., Tang, Z., Yin, L., Morrison, B., Hafez-Khayyata, S., Fu, P., Huang, H., Bagai, R., Jiang, S., Kresak, A., Howell, S., Vasanji, A., Flask, C. A., Halmos, B., Koon, H., & Ma, P. C. (2011). MET-independent lung cancer cells evading EGFR kinase inhibitors are therapeutically susceptible to BH3 mimetic agents. Cancer Research, 71(13), 4494-4505. https://doi.org/10.1158/0008-5472.CAN-10-2668